每经AI快讯，博拓生物（SH 688767，收盘价：38.78元）12月11日晚间发布公告称，截至2025年12月11 日，于秀萍女士通过集中竞价交易和大宗交易的方式合计减持公司股份约448万股，占公司当前总股本 的3%。本次减持计划实施完毕。 每经头条（nbdtoutiao）——白金信用卡权益大缩水：贵宾厅限次、酒店减量⋯⋯银行吐槽没赚头，"羊 毛党"薅了个寂寞 （记者 王瀚黎） 截至发稿，博拓生物市值为58亿元。 2024年1至12月份，博拓生物的营业收入构成为：体外诊断试纸占比92.91%，其他业务占比7.09%。 ...

Group 1 - The core point of the article is that Botao Bio (SH 688767) announced the convening of its fourth second board meeting on August 27, 2025, to review the semi-annual report and its summary for 2025 [1] - For the year 2024, Botao Bio's revenue composition is reported as 92.91% from in vitro diagnostic test strips and 7.09% from other businesses [1] - As of the report, Botao Bio has a market capitalization of 5.9 billion yuan [1]